T Rowe Price Group Forecast, price target & analysts
T Rowe Price Group Target price 2025 - Analyst rating & recommendation
T Rowe Price Group Classifications & Recommendation:
T Rowe Price Group Price Target
| Target Price | $108.57 |
| Price | $106.27 |
| Potential |
2.17%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target T Rowe Price Group 2026 .
The average T Rowe Price Group target price is $108.57.
This is
2.17%
register free of charge
$126.00
18.57%
register free of charge
$90.00
15.31%
register free of charge
|
|
| A rating was issued by 17 analysts: 0 Analysts recommend T Rowe Price Group to buy, 11 to hold and 6 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the T Rowe Price Group stock has an average upside potential 2026 of
2.17%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 7.09 | 7.44 |
| 9.80% | 4.86% | |
| EBITDA Margin | 38.59% | 38.37% |
| 2.09% | 0.56% | |
| Net Margin | 28.79% | 27.60% |
| 7.51% | 4.14% |
10 Analysts have issued a sales forecast T Rowe Price Group 2025 . The average T Rowe Price Group sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an T Rowe Price Group EBITDA forecast 2025. The average T Rowe Price Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 T Rowe Price Group Analysts have issued a net profit forecast 2025. The average T Rowe Price Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 9.16 | 9.21 |
| 18.04% | 0.55% | |
| P/E | 11.54 | |
| EV/Sales | 3.02 |
10 Analysts have issued a T Rowe Price Group forecast for earnings per share. The average T Rowe Price Group <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the T Rowe Price Group stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
T Rowe Price Group...
Current T Rowe Price Group Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keefe, Bruyette & Woods | Market Perform ➜ Market Perform | Unchanged | Feb 06 2025 |
| Barclays | Underweight ➜ Underweight | Unchanged | Feb 06 2025 |
| Wells Fargo | Equal-Weight ➜ Equal-Weight | Unchanged | Feb 06 2025 |
| Barclays | Underweight ➜ Underweight | Unchanged | Jan 17 2025 |
| Wells Fargo | Equal-Weight ➜ Equal-Weight | Unchanged | Jan 14 2025 |
| Keefe, Bruyette & Woods | Market Perform ➜ Market Perform | Unchanged | Jan 13 2025 |
| Morgan Stanley | Equal-Weight ➜ Equal-Weight | Unchanged | Dec 20 2024 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Keefe, Bruyette & Woods: Market Perform ➜ Market Perform
|
Feb 06 2025 |
|
Unchanged
Barclays: Underweight ➜ Underweight
|
Feb 06 2025 |
|
Unchanged
Wells Fargo: Equal-Weight ➜ Equal-Weight
|
Feb 06 2025 |
|
Unchanged
Barclays: Underweight ➜ Underweight
|
Jan 17 2025 |
|
Unchanged
Wells Fargo: Equal-Weight ➜ Equal-Weight
|
Jan 14 2025 |
|
Unchanged
Keefe, Bruyette & Woods: Market Perform ➜ Market Perform
|
Jan 13 2025 |
|
Unchanged
Morgan Stanley: Equal-Weight ➜ Equal-Weight
|
Dec 20 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
